SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-003176
Filing Date
2021-01-06
Accepted
2021-01-06 16:28:04
Documents
14
Period of Report
2021-01-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d100863d8k.htm   iXBRL 8-K 25093
2 EX-99.1 d100863dex991.htm EX-99.1 24692
6 GRAPHIC g100863g0107000401068.jpg GRAPHIC 4937
  Complete submission text file 0001193125-21-003176.txt   191797

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20210106.xsd EX-101.SCH 3086
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20210106_lab.xml EX-101.LAB 18906
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20210106_pre.xml EX-101.PRE 11873
7 EXTRACTED XBRL INSTANCE DOCUMENT d100863d8k_htm.xml XML 3484
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 21510948
SIC: 2834 Pharmaceutical Preparations